EMBLEM Technology Transfer
1
9M
1
1
1
- Areas of investment
Summary
Among the most popular fund investment industries, there are Biotechnology, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Luxendo. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The important activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2017.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the EMBLEM Technology Transfer, startups are often financed by Life Sciences Partners, EMBL Ventures. The meaningful sponsors for the fund in investment in the same round are LSP BioVentures, EMBL Ventures.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Exits
- 1
- Investments by industry
- Biotechnology (1)
- Manufacturing (1)
- Bioinformatics (1)
- Investments by region
-
- Germany (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
- Avg. company exit year
- 2
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Luxendo | 12 Jan 2017 | Biotechnology, Manufacturing, Bioinformatics | Early Stage Venture | 9M | Germany, Baden-Württemberg, Heidelberg |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.